Annex Advisory Services, LLC Repligen Corp Transaction History

Annex Advisory Services, LLC

  • $2.73 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 18, 2021
SELL
$194.77 - $324.21 $195,938 - $326,155
-1,006 Closed
0 $0
Q2 2021

Jul 29, 2021
BUY
$165.87 - $220.95 $166,865 - $222,275
1,006 New
1,006 $201,000
Q1 2021

Apr 22, 2021
SELL
$180.37 - $226.26 $631,295 - $791,910
-3,500 Closed
0 $0
Q4 2020

Jan 28, 2021
BUY
$148.08 - $206.57 $518,280 - $722,995
3,500 New
3,500 $671,000

Others Institutions Holding RGEN

# of Institutions
495
Shares Held
53.9M
Call Options Held
420K
Put Options Held
85.3K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.26B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Annex Advisory Services, LLC Portfolio

Follow Annex Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Annex Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annex Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email